Positive for Hepatitis B surface antigen.
The participant is positive for hepatitis B surface antigen, or hepatitis C ribonucleic acid (RNA)
Active infection requiring therapy, including known positive tests for Hepatitis B surface antigen and hepatitis C virus (HCV) RNA
Active infection, known human immunodeficiency virus infection, or positive test for hepatitis B surface antigen or hepatitis C.
Any known human immunodeficiency virus (HIV) infection, hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
Active systemic infection requiring therapy, positive tests for hepatitis B surface antigen or hepatitis C ribonucleic acid (RNA)
Hepatitis B - antigen positive
The participant is positive for hepatitis B surface antigen, or hepatitis C ribonucleic acid (RNA)
Known hepatitis B surface antigen-positive or known or suspected active hepatitis C infection.
Known hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
Known hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection.
Known history of hepatitis B or hepatitis C infection or known positive test for hepatitis B surface antigen, hepatitis B core antigen, or hepatitis C polymerase chain reaction
Hepatitis B virus surface antigen positive
Known hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
No significant medical illness that in the investigator’s opinion cannot be adequately controlled with appropriate therapy or would compromise the patient’s ability to tolerate this therapy, including\r\n* Unstable cardiovascular function\r\n* Known active hepatitis A, B, or C infection; or known to be positive for hepatitis C virus (HCV) ribonucleic acid (RNA) or hepatitis B surface antigen (HBsAg) (hepatitis B virus [HBV] surface antigen)\r\n* Markedly decreased visual acuity\r\n* Active infection requiring intravenous antibiotics
Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection.
Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection
Known hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
Active infection requiring therapy, including positive tests for hepatitis B surface antigen or hepatitis C ribonucleic acid (RNA)
Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection
Active infection requiring therapy, positive tests for hepatitis B surface antigen or hepatitis C ribonucleic acid (RNA)
Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection
Known hepatitis B surface antigen-positive, or known or suspected active hepatitis\r\nC infection
Active infection requiring therapy, positive tests for hepatitis B surface antigen or hepatitis C ribonucleic acid (RNA)
Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection
Positive tests for hepatitis B surface antigen or hepatitis C ribonucleic acid (RNA)
Active Hepatitis A, B, or C infection or known to be positive for HCV RNA or HBV surface antigen. Patients who have been vaccinated against Hepatitis B and who are positive for ONLY the Hepatitis B surface antibody are permitted to participate in the study.
Hepatitis B surface antigen (+) or hepatitis C positive in preceding six months
Hepatitis B surface antigen positive
Active hepatitis B or C viral infection or hepatitis B surface antigen positive
Known hepatitis B surface antigen-positive, known or suspected active hepatitis C infection (testing not required).
Active systemic infection requiring therapy, positive tests for hepatitis B surface antigen or hepatitis C antibody
Patients with known history of hepatitis B surface antigen-positive, or known history or suspected active hepatitis C infection are not to be enrolled in the study
Active hepatitis B or C viral infection or hepatitis B surface antigen positive
Known hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
Patient is known to be hepatitis B surface antigen-positive or has known active hepatitis C infection.
Known Hepatitis B surface antigen positive or hepatitis C positive
Patient is known to be human immunodeficiency virus (HIV) positive, or have chronic or active hepatitis B (core- or surface antigen-positive) or active hepatitis C infection
Hepatitis B surface antigen positive
Subject who tests positive for hepatitis B surface antigen (HBVsAg) or hepatitis C RNA indicating acute or chronic infection except for subjects with hepatocellular carcinoma;
Positive Hepatitis B surface antigen test
Patients who are known hepatitis B surface antigen-positive are not eligible
Patients who have known or suspected active hepatitis C infections are not eligible; NOTE: patients who are hepatitis C surface antigen-positive are eligible
Active hepatitis B infection as determined by hepatitis B surface antigen.
Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection.
Active infection requiring therapy, positive tests for Hepatitis B surface antigen or Hepatitis C ribonucleic acid (RNA) except in patients with HCC, who meet the following criteria:
Known human immunodeficiency virus (HIV) positive, hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection.
Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection
Ongoing or active infection, known HIV positive, known to be hepatitis B surface antigen-positive or has known or suspected active hepatitis C infection.
Positive Hepatitis B surface antigen test
Active hepatitis B infection as determined by test for hepatitis B surface antigen.
Known or suspected human immunodeficiency virus (HIV), hepatitis B surface antigen-positive status or known or suspected active hepatitis C infection.
Known hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
Active Hepatitis B infection as determined by test for hepatitis B surface antigen.
Patients who are known to be hepatitis B surface antigen positive.
Active evidence of hepatitis B or C infection; hepatitis B surface antigen positive
Known active hepatitis A, B, or C infection; or known to be positive for hepatitis C virus (HCV) ribonucleic acid (RNA) or hepatitis B surface antigen (HBsAg) (hepatitis B virus [HBV] surface antigen)
Subject with known hepatitis B surface antigen (HBsAg) positive status; or known or suspected active hepatitis C infection; or known human immunodeficiency virus (HIV) positive.
Known active hepatitis A, B, or C infection; or known to be positive for hepatitis C virus (HCV) RNA or hepatitis B surface antigen (HBsAg) (hepatitis B virus [HBV] surface antigen)
Known hepatitis B surface antigen positive or known or suspected active hepatitis C infection.
Known to be positive for hepatitis B by surface antigen expression
Known human immunodeficiency virus (HIV) positive or hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection
Known active hepatic disease (known hepatic cirrhosis, hepatitis B surface antigen positive status, or suspected active hepatitis C infection)
Known active hepatic disease (known hepatic cirrhosis, hepatitis B surface antigen positive status, or suspected active hepatitis C infection)
Known human immunodeficiency virus (HIV) positive, hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
Has Known human immunodeficiency virus (HIV) positive, hepatitis B surface antigen-positive status, or known or suspected active hepatitis C infection
Active hepatitis B or hepatitis C infection (hepatitis B surface antigen testing required)
Known active hepatitis A, B, or C infection; or known to be positive for hepatitis C virus (HCV) RNA or hepatitis B surface antigen (HBsAg) (hepatitis B virus [HBV] surface antigen)
Known HIV positive, hepatitis B surface antigen positive or known or suspected active hepatitis C infection.
Known hepatitis B surface antigen positive, or known or suspected active hepatitis C infection.
Known active hepatitis A, B, or C infection; or known to be positive for hepatitis C virus ribonucleic acid (RNA) or hepatitis B virus surface antigen.
Known history of hepatitis B or hepatitis C infection or known positive test for hepatitis B surface antigen, hepatitis B core antigen, or hepatitis C polymerase chain reaction.
Known hepatitis B surface antigen-positive or known or suspected active hepatitis C infection (testing not required).